228 episodes

A podcast on medicine, oncology, & health policy.
Host: Vinay Prasad, MD MPH from University of California, San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com.

Plenary Session Vinay Prasad, MD MPH

    • Science
    • 4.6 • 5 Ratings

A podcast on medicine, oncology, & health policy.
Host: Vinay Prasad, MD MPH from University of California, San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com.

    4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma

    4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma

    Today we have two short monologues for you on recent papers. The first, by popular request, is the problems with the VISION trial, which treated metastatic castration-resistant prostate cancer with lutetium-177–PSMA-617 (Lu-177–PSMA-617) radioligand therapy and standard of care. The second is on the paper recently published in Science titled "Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients".

    Fecal transplant: doi.org/10.1126/science.abb5920

    Back us on Patreon! www.patreon.com/plenarysession

    Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

    • 26 min
    4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021

    4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021

    In today's quick episode, we talk about our new paper out now in JAMA Network Open titled "The Oncologic Drugs Advisory Committee Votes of April 2021—Implications for the Fate of Accelerated Approval"

    ODAC Votes: doi.org/10.1001/jamaoncol.2021.3046

    Back us on Patreon! www.patreon.com/plenarysession

    Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

    • 11 min
    4.07 Questions from a Medical Student with Emma Greenstreet and Dr. Vinay Prasad

    4.07 Questions from a Medical Student with Emma Greenstreet and Dr. Vinay Prasad

    We have a reverse episode for you today! Emma Greenstreet, a second-year medical student at UCSF, interviews our usual host, Dr. Vinay Prasad on why and how he chose hematology/oncology as a specialty, engaging with criticism, mentorship, medical student rotations, choosing a research project, and urging doctors in academia to aim higher.

    Back us on Patreon! www.patreon.com/plenarysession

    Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

    • 49 min
    4.06 CAR-T, Oncology RCTs, Social Media, Myeloma, and Career Decisions with Dr. Rahul Banerjee

    4.06 CAR-T, Oncology RCTs, Social Media, Myeloma, and Career Decisions with Dr. Rahul Banerjee

    We sat down in person with Dr. Rahul Banerjee, a BMT/CAR-T fellow at UCSF, to talk about all manner of topics including CAR-T, randomized trials in oncology (and, specifically, Dr. Banerjee's two recent papers out now), social media, treating Multiple Myeloma, and how people make career decisions.

    What Oncologists Can Learn From COVID-19: doi.org/10.1038/s41571-020-00448-y
    Are Observational, Real-World Studies Suitable: doi.org/10.1001/jamanetworkopen.2020.12119

    Back us on Patreon! www.patreon.com/plenarysession

    Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

    • 1 hr 31 min
    4.05 Exodus from Academia and the Regretful FDA Approval of Aducanumab with Dr. Ameet Sarpatwari

    4.05 Exodus from Academia and the Regretful FDA Approval of Aducanumab with Dr. Ameet Sarpatwari

    Today we are joined by Dr. Ameet Sarpatwari of Harvard Medical School to discuss how so many great minds in oncology are leaving cancer research in academia for industry. We also talk about the evidence (or lack thereof) behind the recent FDA approval of aducanumab to treat Alzheimer's disease.

    Back us on Patreon! www.patreon.com/plenarysession

    Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

    • 53 min
    4.04 Treatment Algorithm for Follicular Lymphoma & Assessing RCTs

    4.04 Treatment Algorithm for Follicular Lymphoma & Assessing RCTs

    Today we have a short monologue for you on just a few topics: a treatment algorithm for follicular lymphoma and our host Dr. Prasad's new paper out now in the European Journal of Clinical Investigation: "Reliable, cheap, fast and few: What is the best study for assessing medical practices? Randomized controlled trials or synthetic control arms?"

    RCTs or Synthetic Control Arms?: doi.org/10.1111/eci.13580

    Back us on Patreon! www.patreon.com/plenarysession

    Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

    • 30 min

Customer Reviews

4.6 out of 5
5 Ratings

5 Ratings

Dr. Sofie Hallager ,

A most needed voice in medicine

Important discussions of evidence based medicine and issues related to it in oncology and hematology, however, these discussions applies to all fields of medicine.

Top Podcasts In Science

Listeners Also Subscribed To